RofecoxibRofecoxib is a COX-2-selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea. Read from the Drugbox of the Wikipedia article Rofecoxib, revision 1377258824.

Property

Value

Formula

C17H14O4S, 314.36 g/mol

Bioavailability

93 %

Protein binding

87 %

Elimination half-life

17 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.